In partnership with the Lieber Institute for Brain Development Maltz Research Laboratories (LIBD), Wake is developing a cutting-edge genetics-based research initiative for safe administration of psychedelic-assisted psychotherapy.
The Wake Genomics Project will be a laboratory screening process integrated with a one of a kind cloud-based AI-Reference library of genetics.
| Fungi Type | Production | Product Development | IRB Approval | Trial Registration | Drug Registration | Recruitment Begins |
|---|---|---|---|---|---|---|
| Fungi Based Microdose Focus: Anxiety and Depression | ||||||
| Fungi Based Microdose Focus: PTSD (Health Disparity Focused) | ||||||
| Fungi Based Microdose Focus: PTSD (Health Disparity Focused) |
Wake is developing a Traumatic Brain Injury study in collaboration with the University of West Indies, Lieber Institute for Brain Development and our partners. This is the first study that brings a genetics-based approach to study the effects of psilocybin on Traumatic Brain Injury. Wake is building an Athletic Council dedicated to research, recruitment and awareness on TBI and psilocybin as a therapeutic.
